Augustina Isioma Ikusemoro: Why Routine Platelet Transfusion Is Not Always Recommended in Dengue
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“In Dengue, low platelets alone are not the enemy – poor clinical judgment is.
One of the most common misconceptions in dengue management is:
‘Low platelet count equals automatic platelet transfusion.’
But the science says otherwise.
Platelet transfusion in dengue is not routine treatment.
Dengue bleeding is not driven by thrombocytopenia alone.
It is also caused by:
- Increased capillary leak
- Platelet dysfunction
- Bone marrow suppression
- Coagulopathy and plasma leakage
So the real question is not:
‘What is the platelet count?’
The better question is:
‘What is the patient’s clinical condition?’
When should platelet transfusion be considered?
- Active or significant bleeding
- Severe thrombocytopenia in selected high-risk patients
- Falling platelet counts with warning signs
- Before invasive procedures when clinically indicated
But in a stable patient without bleeding?
Routine prophylactic platelet transfusion is usually not recommended – even when platelet counts are low.
Why?
Because unnecessary transfusions can lead to:
- Transfusion reactions
- Volume overload
- Wastage of a precious blood resource
The key lesson?
Treat the patient – not just the platelet count.
In transfusion medicine, wisdom is knowing when not to transfuse.
Think clinical. Assess risk. Transfuse wisely. Save lives.
Signature of Blood Doki
Educate. Empower. Elevate.
Better Blood. Better Care. Better Outcomes.”
Find more posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis
-
Oct 18, 2026, 17:04Emna Gouider Belhadjali: Don’t Miss GPAS 2026 on Bleeding Disorders
-
Oct 18, 2026, 16:53Mehran Ghasemzadeh: Microparticle-Associated Mitochondrial DNA in Stored Platelet Products
-
Oct 18, 2026, 16:38Edward Lee Carter: A 15-Minute Blood Test for Brain Hemorrhage?
-
Oct 18, 2026, 16:29Patrick Taylor: Oral vs Transdermal Estrogen and Cardiovascular Risk in Menopausal Women
-
Oct 18, 2026, 16:19Artangela Henry: A Meaningful Week at the SCDAA National Convention
-
Oct 18, 2026, 16:04Emília Araújo։ New Insights Into the Genetics of Hemophilia B Leyden
-
Oct 18, 2026, 15:43André Marcel Harris: Award-Winning Research on Texas Sickle Cell Data Collection
-
Oct 18, 2026, 15:21Eleonora Gambineri: First Results of the IEI-Haem Consortium at ESID 2026